Bojan Ljepoja

A proteomic analysis of an in vitro knock-out of miR-200c

E. Wagner, T. Fröhlich, G. Arnold, 2018, Scientific Reports.

Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification

Ernst Wagner, T. Fröhlich, A. Roidl, 2022, Cancers.

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases

A. Ullrich, C. Bräuchle, E. Wagner, 2016, Oncotarget.

A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF-7 breast cancer cells

E. Wagner, T. Fröhlich, G. Arnold, 2018, International journal of molecular medicine.

Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A

S. Zahler, E. Wagner, J. Rädler, 2019, PloS one.

MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.

E. Wagner, A. Roidl, Jonathan García-Román, 2019, Breast.

Downregulation of GRK5 hampers the migration of breast cancer cells

E. Wagner, T. Fröhlich, G. Arnold, 2019, Scientific Reports.